Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock

Klaus Stahl,Georg F. Lehner,Pedro David Wendel-Garcia,Benjamin Seeliger,Thorben Pape,Bernhard M. W. Schmidt,Heiko Schenk,Julius Schmitt,Andrea Sauer,Lennart Wild,Konrad Peukert,Christian Putensen,Christian Bode,Michael Joannidis,Sascha David
DOI: https://doi.org/10.1186/s13054-024-05142-4
IF: 15.1
2024-11-01
Critical Care
Abstract:Coagulopathy is part of the pathological host response to infection in sepsis. Higher plasma concentrations of both tissue factor (TF) and tissue factor pathway inhibitor (TFPI) are associated with occurrence of disseminated intravascular coagulation (DIC), multi-organ dysfunction and increased mortality in patients with sepsis. Currently no treatment approaches specifically targeting this axis are available. We hypothesize that therapeutic plasma exchange (TPE) might limit this coagulopathy by restoring the balance of plasma proteins.
critical care medicine
What problem does this paper attempt to address?